| Sign In to gain access to subscriptions and/or personal tools. |
Validation of a Cell-Based Screen for Insulin Receptor Modulators by Quantification of Insulin Receptor PhosphorylationJohnson & Johnson Pharmaceutical Research and Development, L.L.C., Spring House, PA
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Raritan, NJ Stimulation of a cell with insulin initiates a signal transduction cascade that results in cellular activities that include phosphorylation of the receptor itself. Measurement of the degree of phosphorylation can serve as a marker for receptor activation. Receptor phosphorylation has been measured using Western blot analysis, which is very low throughput and not easily quantifiable. The goal of this project was to develop a cell-based assay to measure receptor phosphorylation in high throughput. This report describes a cell-based assay for insulin receptor phosphorylation that is robust and amenable to high-volume screening in a microwell format.
Key Words: insulin receptor phosphorylation cell-based assays fluorescence resonance energy transfer
Journal of Biomolecular Screening, Vol. 8, No. 4,
439-446 (2003) |
|
||
